Affimed N.V. (AFMDQ) vs Silexion Therapeutics Corp (SLXN)
- Affimed N.V. AFMDQ 0.00 NaN
- Silexion Therapeutics Corp SLXN 0.15 −21.05%
Affimed N.V. and Silexion Therapeutics Corp are both Biotechnology companies. Affimed N.V. and Silexion Therapeutics Corp are of similar size ($2.8M and $2.7M). Silexion Therapeutics Corp has the higher net margin (0.00% vs −7,834.6%) and the higher return on invested capital (0.00% vs −13,558.8%). Across the 13 metrics below, Silexion Therapeutics Corp leads on 8 and Affimed N.V. on 5.
Valuation
Profitability
| Metric | AFMDQ | SLXN | Biotechnology median |
|---|---|---|---|
| Gross margin | 100.00% | — | 65.16% |
| Operating margin | (7,858.63%) | 0.00% | 0.00% |
| Net margin | (7,834.59%) | 0.00% | 0.00% |
| Free cash flow margin | (8,603.91%) | 0.00% | 0.00% |
| Return on equity | (148.64%) | (17,021.95%) | (56.36%) |
| Return on assets | (86.68%) | (277.96%) | (48.04%) |
| Return on invested capital | (13,558.83%) | 0.00% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack